Skip to Main Content

Paper Details

Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.
Blood Rev
8
2022
AML, Acute myeloid leukemia, Leukemic, Leukemic blast, Sphingolipids, acute myeloid leukemia, bone marrow-derived myeloid progenitor cells, cancer, ceramide, heterogenous malignancy, patient, patients, sphingolipid, sphingolipids, sphingosine-1-phosphate
Author NameAffiliation
Francine E Garrett-BakelmanUniversity of Virginia School of Medicine, United States of America University of Virginia Cancer Center
Francine E Garrett-BakelmanUniversity of Virginia School of Medicine, United States of America University of Virginia Cancer Center
Martin S TallmanMemorial Sloan Kettering Cancer Center
  • 1 - 3

Datasets

Release 1.2